英文药名：CALCICOL Injection 8.5%（Calcium Gluconate Hydrate） 中文药名：葡萄糖酸钙注射剂 生产厂家：Nichi-IKO药业 カルチコール注射液8.5％5mL／カルチコール注射液8.5％10mL 治疗类别名称 补钙 商標名 CALCICOL 一般名 グルコン酸カルシウム水和物（Calcium Gluconate Hydrate） 化学名 Monocalcium di-D-gluconate monohydrate 構造式： 分子式 C12H22CaO14・H2O 分子量 448.39 性状 为白色结晶粉末或颗粒。 微溶于水，并在乙醇（99.5）几乎不溶。 适应病症 改善以下症状的于低血钙 手足抽搐，手足抽搐相关症状 钙在腹腔供应 用法用量 葡萄糖酸钙水合物，通常8.5瓦特/v％（1.83-9.17mEq作为这种药物4.7-23.5mL=钙）成人0.4-2.0克如（0.39mEq/ mL）的溶液内，静脉内每天一次慢慢地（每分钟0.68-1.36mEq=此为每分钟1.7-3.5毫升作为钙药物）被注入。但是，如果在腹腔中使用，但只在口服给药不可能的时间。 此外，增加或减少取决于患者的年龄和症状。 药效药理 防手足抽搐动作，低钙血症的改善作用 它是静脉注射葡萄糖酸钙20毫克/公斤至低钙搐搦狗引起的甲状腺，甲状旁腺卵巢切除术和低钙饮食制作了15分手足抽搐痉挛消失后。此外，血浆钙显著增加。 包装规格 注射液 8.5％：5毫升 5毫升×50安瓿瓶（塑料安瓿） 注射液 8.5％：10毫升 10毫升×50安瓿瓶（塑料安瓿） 制造厂商 Nichi-IKO公司 完整处方资料附件：http://www.info.pmda.go.jp/go/pack/3213400A2047_2_02/ CALCICOL Injection 8.5%（Calcium gluconate hydrate） CALCICOL Injection 8.5% 5mL（カルチコール注射液8.5% 5mL）  Brand name : CALCICOL Injection 8.5% 5mL 　Active ingredient: Calcium gluconate hydrate 　Dosage form: injection 　Print on wrapping:  CALCICOL Injection 8.5% 10mL（カルチコール注射液8.5%10mL）  Brand name : CALCICOL Injection 8.5% 10mL 　Active ingredient: Calcium gluconate hydrate 　Dosage form: injection 　Print on wrapping: Effects of this medicine This medicine supplements calcium deficiency in blood and suppresses tetany (convulsion, muscle spasm, tremoring limbs, etc.) caused by calcium deficiency. It is usually used to treat tetany caused by hypocalcemia and tetany related symptoms and supplement calcium in celiac disease. Before using this medicine, be sure to tell your doctor and pharmacist •If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines. If you have hypercalcemia, nephrolithiasis or renal failure. •If you are pregnant or breastfeeding. •If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.) Dosing schedule (How to take this medicine) •Your dosing schedule prescribed by your doctor is <<to be written by a healthcare professional>> •In general, inject intravenously once a day, slowly. •The duration of use may be decided according to symptoms of the patient. Precautions while taking this medicine • Possible adverse reactions to this medicine The most commonly reported adverse reactions include loss of appetite, nausea/vomiting, constipation, stomach pain and malaise. If any of these symptoms occur, consult with your doctor or pharmacist. The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately. •thirst, excess intake of fluid, diuresis [hypercalcemia] •abdominal/low back pain, bloody urine [lithiasis] The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above. Nichi-iko Pharmaceutical Co.,LtdInjection Revised: 7/2012 The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.